Drug intelligence / Profile preview

Ling-gui-zhu-lian

Development stage: Preclinical
Administration: Oral

Overview

Ling-gui-zhu-lian is a traditional Chinese medicine (TCM) decoction composed of several herbal ingredients, including Codonopsis pilosula, Astragalus mongholicus, Wolfiporia extensa, Atractylodes macrocephala, Ramulus Cinnamomi, Coptis chinensis, and Exocarpium Benincasae. It is being investigated for its clinical efficacy, particularly in combination with Metformin, for the treatment of obese patients with insulin resistance.

Other names: Ling-gui-zhu-lian Decoction苓桂术连汤

Beyond the preview

Go deeper on Ling-gui-zhu-lian.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ling-gui-zhu-lian.

Explore the full profile